S211-1001 Screening compound: (4-{[3-(2-methoxyethyl)-1,2,4-oxadiazol-5-yl]methoxy}piperidino)(3-methyl-1H-pyrazol-5-yl)methanone

S211-1001 Screening compound: (4-{[3-(2-methoxyethyl)-1,2,4-oxadiazol-5-yl]methoxy}piperidino)(3-methyl-1H-pyrazol-5-yl)methanone
S211-1001 Screening compound: (4-{[3-(2-methoxyethyl)-1,2,4-oxadiazol-5-yl]methoxy}piperidino)(3-methyl-1H-pyrazol-5-yl)methanone alternative view

Chemical Structure Depiction of ChemDiv screening compound S211-1001
(4-{[3-(2-methoxyethyl)-1,2,4-oxadiazol-5-yl]methoxy}piperidino)(3-methyl-1H-pyrazol-5-yl)methanone

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S211-1001

Molecular Formula

C16H23N5O4 (C16 H23 N5 O4)

Compound Name

(4-{[3-(2-methoxyethyl)-1,2,4-oxadiazol-5-yl]methoxy}piperidino)(3-methyl-1H-pyrazol-5-yl)methanone

IUPAC name

n/a

SMILES

Cc1n[nH]c(C(N(CC2)CCC2OCc2nc(CCOC)no2)=O)c1

InChI

InChI=1S/C16H23N5O4/c1-11-9-13(19-18-11)16(22)21-6-3-12(4-7-21)24-10-15-17-14(20-25-15)5-8-23-2/h9,12H,3-8,10H2,1-2H3,(H,18,19)

InChI Key

FVJBWROKSUJWRK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29031808

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

349.39

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

0.459

Distribution Coefficient, logD

0.459

Water Solubility, LogSw

-1.50

Polar Surface Area

87.144

Acid Dissociation Constant (pKa)

8.68

Base Dissociation Constant (pKb)

2.63

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

62.50

S211-1001 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S211-1001 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S211-1001?
Check Price and Availability of S211-1001, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S211-1001 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S211-1001
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S211-1001
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S211-1001 available by request